how long to feel effects of glp 1 GLP-1 Side Timeline: Week-by-Week What Expect (and When to GLP-1 Weight Loss and Cellulite

red/far-red: 15:1) of the same intensity

Vanessa Ngan, Staff Writer

MK-677 provides weaker growth hormone stimulation than injectable alternatives

Hypothetical Dosing Considerations While no evidence-based cagrilintide dosage with retatrutide protocol exists, theoretical frameworks based on monotherapy data suggest several principles that would likely apply: Conservative Approach Principles: Start with minimal doses Perhaps 0.3 mg cagrilintide + 2 mg retatrutide weekly Extended titration periods 16-24 weeks to reach target doses instead of standard 8-12 weeks Alternating escalation Increase one compound while holding the other stable Frequent monitoring Weekly check-ins during initial phases Lower maximum doses Perhaps 1.2 mg cagrilintide + 8 mg retatrutide rather than maximum monotherapy doses These suggestions remain purely speculative and should not be interpreted as clinical recommendations